Melioidosis and hairy cell leukemia in 2 travelers returning from Thailand. by Rossi, Benjamin et al.
HAL Id: hal-01844943
https://hal.archives-ouvertes.fr/hal-01844943
Submitted on 15 Oct 2018
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Melioidosis and hairy cell leukemia in 2 travelers
returning from Thailand.
Benjamin Rossi, Loïc Epelboin, Stéphane Jauréguiberry, Maryline Lecso,
Damien Roos-Weil, Jean Gabarre, Philippe Grenier, François Bricaire, Eric
Caumes
To cite this version:
Benjamin Rossi, Loïc Epelboin, Stéphane Jauréguiberry, Maryline Lecso, Damien Roos-Weil, et al..
Melioidosis and hairy cell leukemia in 2 travelers returning from Thailand.. Emerging Infectious Dis-
eases, Centers for Disease Control and Prevention, 2013, 19 (3), pp.503-505. ￿10.3201/eid1903.121329￿.
￿hal-01844943￿
LETTERS
the list of emerging bacterial zoonotic 
agents in wild rodents that could 
be pathogenic for humans. Further 
studies are warranted to evaluate 
the prevalence of this bacterium 
in rodents in other countries and 
to demonstrate that rodents may 
be a source of transmission of this 
bacterium to humans, especially 
immunocompromised patients.
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Melioidosis and 
Hairy Cell  
Leukemia in 2  
Travelers Returning 
from Thailand
To the Editor: Patients with 
underlying medical conditions travel 
more than ever (1), and such travelers 
may be exposed to uncommon 
infections (2). We report 2 cases of 
melioidosis and hairy cell leukemia in 
travelers returning from Thailand.
Case-patient 1 was a 48-year-old 
man hospitalized in Paris with fever, 
asthenia, chills, and pancytopenia 
after returning from a 1-week visit 
to Thailand where he had been in 
flooded regions (Koh Samui and 
Koh Samet). Clinical examination 
showed a temperature of 40°C and 
mucocutaneous pallor. Laboratory 
tests showed a hemoglobin level of 7.9 
g/dL, a platelet count of 33 × 109/L, a 
leukocyte count of 1.3 × 109 cells/L, 
a polymorphonuclear cell count of 
0.77 × 109 cells/L, a monocyte count 
of 0, and a C-reactive protein level of 
158 mg/L. Results of tests for HIV, 
dengue, and malaria were negative.
Presumptive antimicrobial drug 
treatment with piperacillin/tazobactam 
(12 g/1.5 g/d) was initiated at 
admission. A blood smear showed 10% 
hairy cells, and a bone marrow biopsy 
confirmed a diagnosis of hairy cell 
leukemia and interstitial infiltration of 
CD20-positive, monoclonal antibody 
DBA.44–positive, and tartrate-resistant 
acid phosphatase–positive cells.
Because of persistent unexplained 
fever, full-body computed tomography 
(CT) was performed and showed 
multiple liver, spleen, and lung 
abscesses (Figure, panels A and B). 
Culture of a CT scan–guided liver 
abscess puncture specimen was 
positive for Bukholderia pseudomallei 
after 12 days of antimicrobial drug 
treatment. Treatment was changed 
to ceftazidime (120 mg/kg/d) 
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(TMP/SMX) (10/50 mg/kg/d) and oral 
doxycycline (200 m/d) for 3 weeks. 
The outcome was good.
Oral treatment with TMP/SMX 
and doxycycline (200 mg/d) was 
continued for 20 weeks. Treatment 
for hairy cell leukemia with cladribine 
was initiated after 10 weeks of 
antimicrobial drug treatment. Two 
years later, the patient showed 
complete remission of hairy cell 
leukemia and melioidosis.
Case-patient 2 was a 64-year-
old man hospitalized in Paris for 
persistent fever 16 days after his return 
from Thailand. Two months earlier in 
Thailand, he had received treatment 
for hepatosplenic melioidosis with 
ceftazidime (120 mg/kg/d), TMP/SMX 
(10/50 mg/kg/d), and doxycycline 
(200 mg/d) for 15 days, and then 
oral amoxicillin/clavulanic acid (3 
g/d) for 3 months. At admission, he 
had fever, chills, abdominal pain, 
and cough. Clinical examination 
showed a temperature of 40°C and 
left lung crackles. Chest and abdomen 
CT images showed a focus of lung 
consolidations (Figure, panels C and 
D), left pleural effusion, pericarditis, 
and spleen abscesses. Laboratory tests 
showed a leukocyte count of 1.05 × 109 
cells/L, a monocyte count of 0.04 × 109 
cells/L, a hemoglobin level of 7.9 g/
dL, a platelet count of 62 × 109/L, and a 
serum ferritin level of 8,530 IU/L.
Blood cultures were positive 
for B. pseudomallei. The strain was 
sensitive to amoxicillin/clavulanic 
acid. Bone marrow aspiration and 
biopsy showed hemophagocytosis 
and interstitial infiltration of CD20-
positive, monoclonal antibody 
DBA.44–positive, CD 103-positive, 
CD25-positive, CD11c-positive, and 
CD123-positive cells, leading to a 
diagnosis of hairy cell leukemia. The 
patient was given a 2-week course 
of intravenous TMP/SMX (50 mg/10 
mg/kg/d), oral doxycycline (4 mg/
kg/d), and intravenous ceftazidime 
(120 mg/kg/d), followed by a 6-month 
course of oral TMP/SMX (10 mg/50 
mg/kg/d) and doxycycline (200 mg/d). 
The condition of the patient improved 
and pancytopenia resolved. Thus, 
he did not require any treatment for 
hairy cell leukemia. No relapse of 
melioidosis occurred.
Melioidosis is endemic to the 
Pacific region and Southeast Asia (3,4). 
Most cases reported in other regions 
are imported (5). In Thailand, where 
both patients had traveled, the number 
of cases increased from 11.5/100,000 
inhabitants in 1997 to 21.3/100,000 
in 2006 (6). The 2 main routes of 
transmission are transcutaneous and 
aerosols. Natural disasters, such 
as flooding, are a risk factor for 
melioidosis, as for case-patient 1.
This disease has an overall 
mortality rate of 50%. The clinical 
spectrum ranges from acute septicemia 
(mortality rate 80%) to the subacute 
form. B. pseudomallei is difficult to 
detect by culture of biologic samples, 
and serologic analysis or PCR for this 
bacteria are not routinely available. 
Therefore, a diagnosis of melioidosis 
can be easily missed.
Melioidosis occurs mainly in 
patients with underlying diseases 
such as diabetes (37%–60% of cases), 
chronic alcoholism (12%–39%), 
thalassemia, and chronic nephropathy, 
and in persons receiving long-term 
corticosteroid treatment (7). Reports 
of patients with melioidosis and 
hematologic malignancies or solid 
cancers are scarce (4,5,7). Hairy cell 
leukemia could now be included in 
this group of diseases.
Hairy cell leukemia is a rare 
chronic B-cell lymphoproliferative 
disorder characterized by pancytopenia; 
splenomegaly; and infiltration of the 
bone marrow, spleen, and liver by 
malignant B cells that have hair-like 
cytoplasmic projections (8,9). The 
incidence of hairy cell leukemia is 
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Figure.	Computed	 tomography	 (CT)	 images	of	 the	chest	and	abdomen	of	 case-patient	1	
showing	A)	 a	 subpleural	 nodular	 and	 cavitary	 lesion	 (arrow)	 in	 the	 left	 upper	 lobe	of	 the	
lung	and	B)	multiple	small	round	liver	abscesses,	seen	as	multiple	foci	of	ill-defined	areas	
of	hypoattenuation	 (arrows),	and	enlargement	of	 the	spleen.	CT	 images	of	 the	chest	and	
abdomen	of	case-patient	2	showing	C)	a	focal	area	of	parenchymal	consolidation	in	the	left	
lung	associated	with	an	ipsilateral	mild	pleural	effusion	and	D)	and	a	spleen	abscess	(arrow).
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<1 case/100,000 population/year, and 
the disease accounts for ≈2%–3% of 
all leukemias in adults in the United 
States (8). Infections are a common 
complication for patients with this 
disease (10).
These 2 cases of imported 
melioidosis show that travelers with 
hematologic malignancies are at risk 
for such infections (1). Immuno-
compromised travelers might be first 
sentinels for ongoing endemic diseases. 
When travelers return with uncommon 
diseases, physicians should check 
for underlying diseases. Physicians 
providing care for patients with hairy 
cell leukemia should be aware of the 
risk for contracting melioidosis.
Acknowledgment
We thank Laurent Meyer for 
reviewing the manuscript.
Benjamin Rossi,1  
Loïc Epelboin,1  
Stéphane Jauréguiberry, 
Maryline Lecso,  
Damien Roos-Weil,  
Jean Gabarre,  
Philippe A. Grenier,  
François Bricaire,  
and Eric Caumes
Author	 affiliations:	 Groupe	 Hospitalier	
Pitié-Salpêtrière,	 Paris,	 France	 (B.	 Rossi,	
L.	 Epelboin,	 S.	 Jauréguiberry,	 M.	 Lecso,	
D.	 Roos-Weil,	 J.	 Gabarre,	 P.A.	 Grenier,	
F.	 Bricaire,	 E.	 Caumes);	 and	 Université	
Pierre	 et	 Marie	 Curie–Paris	 VI,	 Paris	 (L.	
Epelboin,	 S.	 Jauréguiberry,	 D.	 Roos-Weil,	
P.A.	Grenier,	F.	Bricaire,	E.	Caumes)
1These	 authors	 contributed	 equally	 to	 this	
article.
DOI:	http://dx.doi.org/10.3201/eid1903.121329
References
  1.  Wieten RW, Leenstra T, Goorhuis A, 
van Vugt M, Grobusch MP. Health risks 
of travelers with medical conditions: 
a retrospective analysis. J Travel 
Med. 2012;19:104–10. http://dx.doi.
org/10.1111/j.1708-8305.2011.00594.x
  2.  McCarthy AE, Mileno MD. Prevention 
and treatment of travel-related infections 
in compromised hosts. Curr Opin Infect 
Dis. 2006;19:450–5. http://dx.doi.
org/10.1097/01.qco.0000244050.15888.6f
  3.  Cheng AC, Currie BJ. Melioidosis: 
epidemiology, pathophysiology, and 
management. Clin Microbiol Rev. 2005; 
18:383–416. http://dx.doi.org/10.1128/
CMR.18.2.383-416.2005
  4.  White NJ. Melioidosis. Lancet. 
2003;361:1715–22. http://dx.doi.org/ 
10.1016/S0140-6736(03)13374-0
  5.  Cahn A, Koslowsky B, Nir-Paz R, Temper 
V, Hiller N, Karlinsky A, et al. Imported 
melioidosis, Israel, 2008. Emerg Infect 
Dis. 2009;15:1809–11. http://dx.doi.
org/10.3201/eid1511.090038
  6.  Limmathurotsakul D, Wongratanacheewin 
S, Teerawattanasook N, Wongsuvan 
G, Chaisuksant S, Chetchotisakd P, 
et al. Increasing incidence of human 
melioidosis in northeast Thailand. Am J 
Trop Med Hyg. 2010;82:1113–7. http://
dx.doi.org/10.4269/ajtmh.2010.10-0038
  7.  Salam AP, Khan N, Malnick H, Kenna 
DT, Dance DA, Klein JL. Melioidosis 
acquired by traveler to Nigeria. Emerg 
Infect Dis. 2011;17:1296–8. http://dx.doi.
org/10.3201/eid1707.110502
  8.  Goodman GR, Bethel KJ, Saven A. Hairy 
cell leukemia: an update. Curr Opin 
Hematol. 2003;10:258–66. http://dx.doi.
org/10.1097/00062752-200307000-00002
  9.  Bouroncle BA, Wiseman BK, Doan CA. 
Leukemic reticuloendotheliosis. Blood. 
1958;13:609–30.
10.  Kraut E. Infectious complications in 
hairy cell leukemia. Leuk Lymphoma. 
2011;52(Suppl 2):50–2. http://dx.doi.org/
10.3109/10428194.2011.570819
Address for correspondence: Loïc Epelboin, 
Service des Maladies Infectieuses et Tropicales, 
Groupe Hospitalier Pitié-Salpêtrière, 47–83 
Blvd de l’Hôpital, 75013 Paris, France; e-mail: 
epelboincrh@hotmail.fr
Plague Epidemics 
and Lice,  
Democratic  
Republic of  
the Congo
To the Editor: Plague, a zoonotic 
disease caused by the gram-negative 
bacterium Yersinia pestis, is transmit-
ted to humans by the bites of infected 
fleas (such as Xenopsylla cheopis), 
scratches from infected animals, and 
inhalation of aerosols or consump-
tion of food contaminated with Y. 
pestis (1). Decades ago, Blanc and 
Baltazard proposed that human-to-
human transmission of Y. pestis could 
be mediated by human ectoparasites, 
such as the human body louse (2). 
This hypothesis was further support-
ed by experimental data from animal 
models (3).
To further test this hypothesis 
among humans, we conducted a field 
assessment in April 2010, in which 
we collected body and head lice from 
persons living in a highly plague-
endemic area near the Rethy Health 
District, Province Orientale, Demo-
cratic Republic of the Congo. This 
health district has 157,000 inhabit-
ants, and during 2004–2009 it had 
more suspected plague cases (1,624 
cases of suspected plague, 39 deaths) 
than any other health district in the 
Democratic Republic of the Congo. 
In April 2010, we visited the dwell-
ings of 10 patients for whom sus-
pected cases of plague had been di-
agnosed during January–April 2010. 
All patients had symptoms typical of 
bubonic plague, and their illnesses 
were reported as suspected bubonic 
plague. However, because of the lack 
of laboratory facilities in Rethy, none 
of these diagnoses could be micro-
biologically confirmed. 
A total of 154 body lice and 35 
head lice were collected from clothes 
and hair of persons living in or near 
the patients’ dwellings. Body lice 
were preserved in ethanol before 
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Letters
Letters commenting on recent articles as 
well as letters reporting cases, outbreaks, 
or original research are welcome. Letters 
commenting on articles should contain 
no more than 300 words and 5 referenc-
es; they are more likely to be published if 
submitted within 4 weeks of the original 
article’s publication. Letters reporting 
cases, outbreaks, or original research 
should contain no more than 800 words 
and 10 references. They may have 1  
Figure or Table and should not be divid-
ed into sections. All letters should con-
tain material not previously published 
and include a word count.
